PYC pyc therapeutics limited

Gilead buys Kite for $12B, page-9

  1. 6,326 Posts.
    lightbulb Created with Sketch. 22833
    A bit of light reading, for anyone interested…

    The first is from a blog on peptide therapeutics written by the CBO of Bicycle Therapeutics. You could call it her Peptides Pitch for Taxi Drivers. I found it interesting and informative.

    From Poisons To Pills: Peptides
    https://lifescivc.com/2017/02/poisons-pills-peptides/

    The title alone makes the second worthwhile reading

    Cell-penetrating peptides—the Swiss Army knife of cancer vaccines
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839312/

    And the final is a follow up paper by the team at Stanford researching MYC which WW highlighted earlier this year.

    MYC: Master Regulator of Immune Privilege
    http://www.cell.com/trends/immunology/abstract/S1471-4906(17)30013-3
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.26
Change
-0.035(2.70%)
Mkt cap ! $734.9M
Open High Low Value Volume
$1.31 $1.31 $1.26 $2.681M 2.075M

Buyers (Bids)

No. Vol. Price($)
2 3081 $1.25
 

Sellers (Offers)

Price($) Vol. No.
$1.30 700 1
View Market Depth
Last trade - 16.11pm 28/07/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.